NR1H4 and cholestasis: To further lower the bile salt pool size and simultaneously dampen the compensatory bile salt synthesis, we also used the Farnesoid X receptor (FXR) agonist obeticholic acid (OCA), which is expected to have largely left the enterohepatic circulation at the onset of the cholestasis with this experimental design.